Monteloeder

Elche, Spain Founded: 1996 • Age: 30 yrs Acquired By Suanfarma
Nutraceutical ingredients are supplied for supplements, cosmetics, and nutrition.

About Monteloeder

Monteloeder is a Healthcare company based in Elche (Spain) founded in 1996, and was acquired by Suanfarma in February 2022. Nutraceutical ingredients are supplied for supplements, cosmetics, and nutrition. Its chief executive, as recorded, is Arturo Lizon. Its focus areas include Life Sciences, Nutraceuticals Tech, Nutraceutical Ingredients and Plant Extracts.

Company details

Monteloeder was founded in 1996 in Elche, Spain, as a provider of nutraceutical ingredients derived from plant extracts including fruits, herbs, bark, leaves, and seeds. These ingredients are utilized in food supplements, cosmetic products, beverages, and animal nutrition sectors. An application is also offered by the company to monitor health outcomes following product use. Operations focus on nutritional properties for various applications.

  • Headquarters Elche, Spain
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website monteloeder.com
  • Social LinkedIn X Facebook
  • Acquired by Suanfarma (Feb 2022)
Key Metrics

Funding Insights of Monteloeder

  • Total Rounds 5
  • Last Round Grant — $1.14M
  • First Round $55,188

    (Jul 2015)

  • Investors Count 2

All 5 funding rounds of Monteloeder with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2019$1.14MGrant––
Oct 2017$1.23MGrant––
Jan 2017$1.1MGrant––
Oct 2015$55,006Grant––
Jul 2015$55,188Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Monteloeder

Monteloeder has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Suanfarma, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Generics, nutraceuticals, and APIs are developed by Suanfarma.
1993suanfarma.comMadrid, Spain
Premium access

Investor details for Monteloeder

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Monteloeder

6 people are tracked at Monteloeder (4 in leadership, 2 in team).

NameRoleGroup
Arturo Lizon
CEOLeadership
IGNACIO CARTAGENA MARTINEZ
Vice PresidentLeadership
Fran Cremades
Technical & Operations Director. R&d New Developments.Leadership
Marcos Lopez Diaz
Regional Director - USALeadership
Antonio Pascual Albarranch Sendra
Logistics & Production ManagerTeam
JANE LEE
Asia Technical & Regulatory Market Development ManagerTeam
Premium access

Complete people profiles for Monteloeder

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Monteloeder

4 dated milestones of Monteloeder across 26 years, from founding to its latest funding, stage changes and deals.

  1. Founded Monteloeder is founded.
  2. Funding First funding round of $55K.
  3. Funding Latest funding round, Grant, of $1.1M.
  4. Exit Acquired by Suanfarma.

Web traffic of Monteloeder

The website of Monteloeder (monteloeder.com) receives about 2.2K visits a month.

  • Monthly visits
    2.2K

    ▲ 27.5% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Monteloeder

Premium access

Complete news archive for Monteloeder

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Monteloeder

Monteloeder was founded in 1996 and raised its 1st funding round 19 years after it was founded.

Monteloeder is headquartered in Elche, Spain. It is registered at Elche, Valencian Community, Spain.

Arturo Lizon is the CEO of Monteloeder, as recorded in our data.

Monteloeder was founded in 1996 in Elche, Spain, as a provider of nutraceutical ingredients derived from plant extracts including fruits, herbs, bark, leaves, and seeds. These ingredients are utilized in food supplements, cosmetic products, beverages, and animal nutrition sectors. An application is also offered by the company to monitor health outcomes following product use. Operations focus on nutritional properties for various applications.

Monteloeder has 3 investors. Key investors include Suanfarma, European Union, and EIC Fund.

Yes. Monteloeder was acquired by Suanfarma in February 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available